Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Pan-RAS-IN-6

😃Good
Catalog No. T89850

Pan-RAS-IN-6 (compound 24) serves as a DUSP6 inhibitor, effectively reducing MAPK activation in the NCI-H1373-Luc model (DUSP6). It concurrently exhibits notable tumor growth inhibition and regression in the NSCLC brain metastasis mouse model. The compound displays high selectivity and potent inhibitory effects, particularly on KRAS mutation-associated signaling pathways. It demonstrates varied inhibitory activities against distinct KRAS mutants and their interacting proteins. The IC 50 values for KRAS G12C, G12D, and G12V are 1.3 nM, 4.7 nM, and 0.3 nM, respectively.

Pan-RAS-IN-6

Pan-RAS-IN-6

😃Good
Catalog No. T89850
Pan-RAS-IN-6 (compound 24) serves as a DUSP6 inhibitor, effectively reducing MAPK activation in the NCI-H1373-Luc model (DUSP6). It concurrently exhibits notable tumor growth inhibition and regression in the NSCLC brain metastasis mouse model. The compound displays high selectivity and potent inhibitory effects, particularly on KRAS mutation-associated signaling pathways. It demonstrates varied inhibitory activities against distinct KRAS mutants and their interacting proteins. The IC 50 values for KRAS G12C, G12D, and G12V are 1.3 nM, 4.7 nM, and 0.3 nM, respectively.
Pack SizePriceAvailabilityQuantity
10 mgInquiryBackorder
50 mgInquiryBackorder
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Pan-RAS-IN-6 (compound 24) serves as a DUSP6 inhibitor, effectively reducing MAPK activation in the NCI-H1373-Luc model (DUSP6). It concurrently exhibits notable tumor growth inhibition and regression in the NSCLC brain metastasis mouse model. The compound displays high selectivity and potent inhibitory effects, particularly on KRAS mutation-associated signaling pathways. It demonstrates varied inhibitory activities against distinct KRAS mutants and their interacting proteins. The IC 50 values for KRAS G12C, G12D, and G12V are 1.3 nM, 4.7 nM, and 0.3 nM, respectively.
Targets&IC50
KRas G12V:0.3 nM, KRas G12C:1.3 nM, KRas G12D:4.7 nM
In vitro
Pan-RAS-IN-6 inhibits cell proliferation in NCI-H23, NCI-H358, NCI-H2444, RKN, and SW620 with IC50 values of 0.17 nM, 0.12 nM, 0.17 nM, 0.045 nM, and 0.1 nM, respectively. The compound demonstrates IC50 values against KRAS G12V, wild-type KRAS, wild-type HRAS, and wild-type NRAS-BRAF with CYPA interaction of 7 nM, 32 nM, 38 nM, and 35 nM, respectively; and in conditions of G12C, G12D, and G12V, the IC50 values for KRAS-BRAF with CYPA interaction are 9.7 nM, 49.5 nM, and 7.1 nM. Additionally, Pan-RAS-IN-6 inhibits pERK with IC50 values of less than 0.6 nM for G12C and G12V, and 0.9 nM for G12D.
In vivo
Pan-RAS-IN-6, administered orally at a dose of 30 mg/kg once daily, inhibits tumor growth and promotes tumor regression in a mouse model of non-small cell lung cancer (NSCLC) brain tumors. Additionally, this compound reduces the expression of DUSP6 in the brains of the NCI-H1373-Luc model.
Chemical Properties
Molecular Weight837.08
FormulaC46H60N8O5S
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Pan-RAS-IN-6 | purchase Pan-RAS-IN-6 | Pan-RAS-IN-6 cost | order Pan-RAS-IN-6 | Pan-RAS-IN-6 in vivo | Pan-RAS-IN-6 in vitro | Pan-RAS-IN-6 formula | Pan-RAS-IN-6 molecular weight